Determination of Real-world Single-center Experience with Direct-acting Antivirals for Improvement of Liver Fibrosis after Chronic Hepatitis C Treatment
Anum Mari, Mohammad Masood Khoso, Alina Saeed, Sana Ahmed, Kiran Mari & Riaz Hussain · Journal of Pharmaceutical Research International · 2022
Background and Aims: Chronic Hepatitis C virus is the leading cause of morbidity and mortality. Conversion to liver fibrosis and decompensated liver cirrhosis is common if left untreated. Direct-acting Antiviral agents (DAA) may help in liver fibrosis associated burden. Consideri...
Open access
Research Article
10.9734/jpri/2022/v34i14B35680